Home
Syncom Formulations (india) Ltd PE Ratio

Syncom Formulations (India) Ltd
NSE: SYNCOMFORMUL
PE
Key Highlights
- The P/E Ratio of Syncom Formulations (India) Ltd is 40.5 as of 22 Feb 12:08 PM .
- The P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 41.4 on March 2024 . This represents a CAGR of -3.59% over 3 years.
- The Latest Trading Price of Syncom Formulations (India) Ltd is ₹ 17 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Syncom Formulations (India) Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Syncom Formulations (India) Ltd
Company Fundamentals for Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd
NSE: SYNCOMFORMUL
Share Price
Market Price of Syncom Formulations (India) Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 17 |
20 Feb 2025 | 17.33 |
19 Feb 2025 | 17.01 |
18 Feb 2025 | 16.67 |
17 Feb 2025 | 17.16 |
14 Feb 2025 | 17.57 |
13 Feb 2025 | 18.04 |
12 Feb 2025 | 18.06 |
11 Feb 2025 | 18.34 |
10 Feb 2025 | 18.01 |
SWOT Analysis Of Syncom Formulations (India) Ltd
BlinkX Score for Syncom Formulations (India) Ltd
Asset Value vs Market Value of Syncom Formulations (India) Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Syncom Formulations (India) Ltd | 1598 | 40.48 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Syncom Formulations (India) Ltd | 1598 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Syncom Formulations (India) Ltd Explained
₹1598
Market cap
₹39
Earnings
40.5X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Syncom Formulations (India) Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Syncom Formulations (India) Ltd
Historical Revenue, EBITDA and Net Profit of Syncom Formulations (India) Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Syncom Formulations (India) Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Syncom Formulations (India) Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Syncom Formulations (India) Ltd
About Syncom Formulations (India) Ltd
- Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92.
- The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
- Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
- Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.
Syncom Formulations (India) Ltd News Hub
Nifty slips below 24,200 level; Nifty bank shares buck trend; HDFC Bank drops 2.93%
The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped bel
Read more
13 Aug 24
Syncom Formulations gains after Q1 PAT rises over 73% YoY
Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure
Read more
13 Aug 24
Syncom Formulations (India) consolidated net profit rises 73.41% in the June 2024 quarter
Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 202
Read more
12 Aug 24
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 Augus
Read more
06 Aug 24